Sm Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
- Paid Up Capital ₹ 2.50 M
- Company Age 1 Year 1 Month
About Sm Therapeutics
Sm Therapeutics Private Limited (STPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 January 2024 (One year and one month 6 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Professional Services Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 2.50 M, as per Ministry of Corporate Affairs (MCA) records.
Krishna Kuchipudi, Kuchipudi Vanaja, and Koti Tiyyagura serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U72100TS2024PTC181179
- Company No.
181179
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jan 2024
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Sm Therapeutics?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Koti Tiyyagura  | Director | 18-Jan-2024 | Current |
| Krishna Kuchipudi | Director | 18-Jan-2024 | Current |
| Kuchipudi Vanaja | Director | 18-Jan-2024 | Current |
Financial Performance of Sm Therapeutics.
Enhance accessibility to Sm Therapeutics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Sm Therapeutics?
Unlock access to Sm Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Scires Technologies Private LimitedKoti Tiyyagura is a mutual person
Jeevan Scientific Technology LimitedKrishna Kuchipudi is a mutual person
Jeevana Mitra Constructions LlpKrishna Kuchipudi and Kuchipudi Vanaja are mutual person
- Jstl Pharma Llp
Krishna Kuchipudi and Kuchipudi Vanaja are mutual person
- Naya Pharma Private Limited
Krishna Kuchipudi and Kuchipudi Vanaja are mutual person
- Nayas Laboratories Private Limited
Krishna Kuchipudi, Kuchipudi Vanaja and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sm Therapeutics?
Unlock and access historical data on people associated with Sm Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sm Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sm Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.